Elon Musk Weighs In… And Fed Survey Results 5/20/25
CNBC's "Fast Money"
00:00
Big Pharma Moves and Retail Strategies
This chapter explores Pfizer's $6 billion collaboration with China's 3S Bio to innovate cancer treatments, shedding light on the growing investment in the Chinese pharmaceutical market. It also touches upon Target's earnings outlook and strategic responses to pricing pressures, alongside comparisons to Walmart’s performance.
Transcript
Play full episode
